Further, we generated SLC38A2-deficient B16-OVA (Cas9+) tumour cells (Extended Data Fig. 4g) and performed stable isotope tracing assays of glutamine and other known substrates of SLC38A236,37. Here, SLC38A2 is linked to neoplasm.